Delivery included to the United States

NUCYNTA ER Drug Profile, 2024

NUCYNTA ER Drug Profile, 2024 NUCYNTA ER (Tapentadol Hydrochloride) Drug Patents, FDA Exclusivity, Litigation, Drug Prices - Drugpatentwatch Business Intelligence Reports

Paperback (10 Jan 2024)

Not available for sale

Out of stock

This service is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publisher's Synopsis

NUCYNTA ER Drug Profile, 2024

This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

Book information

ISBN: 9798875720017
Publisher: Amazon Digital Services LLC - Kdp
Imprint: Independently Published
Pub date:
Language: English
Number of pages: 144
Weight: 349g
Height: 279mm
Width: 216mm
Spine width: 8mm